Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 49.60
+0.20 (0.40%)
Oct 28, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 16.31 billion as of October 28, 2026. It is the 14,387th most valuable company in the world and the 500th biggest in Taiwan. Its market cap has increased by 35.33% in one year.
Market Cap
16.31B
Enterprise Value
15.37B
Revenue
573.85M
Global Rank
Country Rank
#500 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 16.31B, an increase of 475.17%. That is a compound annual growth rate of 16.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 16.31B | 31.39% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.85B |
| CHO Pharma | 22.47B |
| Sunmax Biotechnology | 22.28B |
| TaiMed Biologics | 16.67B |
| Ever Supreme Bio Technology | 15.16B |
| EirGenix | 14.57B |
| Gongwin Biopharm Holdings | 13.99B |
| Steminent Biotherapeutics | 13.98B |